Stockreport

Annovis to Highlight Buntanetap's Alzheimer's Research Progress with Presentations at CTAD 2024 [Financial Post (Toronto, Ontario, Canada)]

Annovis Bio, Inc.  (ANVS) 
PDF MALVERN, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) — via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company develop [Read more]